EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

High‐Dose Dual Therapy Versus Bismuth‐Containing Quadruple Therapy as Rescue Treatment for Helicobacter pylori Infection: Systematic Review and Meta‐Analysis

Liang Zhang, Jian Liu, Da Li, Yali Wang iD

Helicobacter · 2026

DOI: 10.1111/hel.70133 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Helicobacter, 2026. Verfasst von Liang Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Hospital of Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Helicobacter Infections, Bismuth, Anti-Bacterial Agents, Helicobacter pylori. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Bismuth‐containing quadruple therapy (BQT) is recommended for H. pylori rescue treatment, but many patients cope with pill burden and adverse events. High‐dose dual therapy (HDDT) may be easier to tolerate. We compared HDDT with BQT in rescue therapy. Materials and Methods We followed PRISMA 2020 ( PROSPERO CRD420251266898 ) and searched PubMed / MEDLINE , Embase, Cochrane CENTRAL , Web of Science Core Collection, CiNii Research, and Major Chinese Databases ( CNKI , Wanfang Data, and VIP ) through December 16, 2025. We pooled head‐to‐head rescue RCTs comparing HDDT ( PPI / PCAB + Amoxicillin ≥ 3 g/Day, ≥ TID ) with BQT using random‐effects models. risk of bias was assessed with RoB 2 and certainty with GRADE . TSA assessed information size for the primary ITT outcome.

Results

Ten RCTs ( n = 2407) showed comparable ITT eradication for HDDT vs. BQT (79.9% vs. 79.9%, RR 1.01, 95% CI 0.97–1.05; I 2 = 3.9%). Any adverse events were less frequent with HDDT (122/1135, 10.7%) than BQT (334/1123, 29.7%). The corresponding meta‐analysis (expressed as AE‐free so that RR > 1 favors HDDT) showed RR 1.27, 95% CI 1.15–1.41. TSA suggested that the required information size for the primary ITT outcome was reached, making a clinically important (≥ 10%) relative difference in ITT eradication unlikely.

Conclusions

In rescue patients without penicillin allergy, HDDT achieves eradication comparable to BQT while causing far fewer adverse events. HDDT is a practical rescue option when BQT is poorly tolerated, although most evidence comes from China and reporting of adherence and resistance is uneven.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsBismuthAnti-Bacterial AgentsHelicobacter pyloriHumansDrug Therapy, CombinationAmoxicillinTreatment OutcomeRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

H. pyloribismuth‐containing quadruple therapyhigh‐dose dual therapymeta‐analysisrescuesystematic review

Substanzen

BismuthAnti-Bacterial AgentsAmoxicillin

Autor:innen und Institutionen

  • The First Hospital of Tsinghua University, Beijing, China.

ORCID-Profile: Yali Wang

Zitieren

APA

Zhang, L., Liu, J., Li, D., & Wang, Y. (2026). High‐Dose Dual Therapy Versus Bismuth‐Containing Quadruple Therapy as Rescue Treatment for Helicobacter pylori Infection: Systematic Review and Meta‐Analysis. Helicobacter. https://doi.org/10.1111/hel.70133

Vancouver

Zhang L, Liu J, Li D, Wang Y. High‐Dose Dual Therapy Versus Bismuth‐Containing Quadruple Therapy as Rescue Treatment for Helicobacter pylori Infection: Systematic Review and Meta‐Analysis. Helicobacter. 2026. doi:10.1111/hel.70133

BibTeX
@article{Zhang2026,
  author = {Zhang, Liang and Liu, Jian and Li, Da and Wang, Yali},
  title = {High‐Dose Dual Therapy Versus Bismuth‐Containing Quadruple Therapy as Rescue Treatment for Helicobacter pylori Infection: Systematic Review and Meta‐Analysis},
  journal = {Helicobacter},
  year = {2026},
  doi = {10.1111/hel.70133}
}
Kostenlos starten →